- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05756868
The Effect of Time-Restricted Feeding on Anthropometry, Biochemical Parameters, Diet Quality and Eating Behavior
The Effect of Time-Restricted Feeding Intervention on Anthropometric Measurements, Biochemical Parameters, Diet Quality and Eating Behavior in Overweight Female Individuals
The goal of this randomized controlled trial is to to determine the effects of time-restricted feeding intervention on body weight, body composition, biochemical parameters and eating behaviors in overweight female individuals.
The main questions it aims to answer are:
- Does time-restricted feeding intervention reduce daily energy intake?
- Does time-restricted dietary intervention result in body weight and body fat loss?
- Does time-limited nutritional intervention lead to improvements in biochemical parameters?
- Does time-restricted feeding intervention improve eating behavior and eating awareness?
- Does time-restricted feeding intervention adversely affect diet quality?
The participants in the intervention group will receive a time restricted feeding intervention (first meal at 10:00, last meal at 18:00) for 6 weeks. Meals of the participants are planned as 8 hours of eating and 16 hours of fasting.
Participants in the control group will not receive any dietary intervention.
Study Overview
Detailed Description
Following the ethics committee approval, the study will be carried out with the participants who applied to the Famagusta State Hospital Internal Medicine Polyclinic, Specialist Umut Hakligil.
In order to start the study, TR Ministry of Health Nicosia Dr. Necessary permissions were obtained from the Ethics Committee of Burhan Nalbantoğlu State Hospital.
The study is planned to be conducted with 40 female participants, who were not diagnosed with any disease by the physician, aged 19-65, slightly obese, with a BMI of 24.9-29.9 kg/m².
Before being included in the research, participants will be informed about the purpose of the research and the applications to be made during the research.
This information was supported with the valid consent form.
Data Collection Tool: A questionnaire form developed in line with the research purpose was used as a data collection tool in the research.
While collecting data on the individuals participating in the research, the "face-to-face interview method" (mask and distance due to the covid-19 pandemic) by taking necessary precautions such as rules of thumb) will be applied.
Beginning of the Study:
Participants who meet the study criteria and agree to participate in the study will be randomly assigned to the control group or intervention group.
Control group protocol; participants randomized to the control group will not receive any dietary intervention. In this process, how all participants should be asked before starting the study.
If they are fed, they will be asked to continue in the same way and to maintain their physical activity level.
- Intervention group protocol; participants randomized to the intervention group will receive a time-restricted feeding intervention for 6 weeks without energy restriction (adlibitum). Meals of the participants will be planned as 8 hours of eating and 16 hours of fasting.
Meal timing will be set as follows:
- First meal at 10:00,
- Last meal at 18:00 in the evening
Participants will be asked not to consume anything other than non-calorie drinks (water, only soda, unsweetened herbal teas, etc.) between 18:00 in the evening and 10:00 in the morning.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Famagusta, Cyprus, 99628
- Eastern Mediterranean University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- 19-65 age range
- Female
- BMI: 24.9-29.9 kg/m²
- Maintaining general activity and exercise habits during the study period
- Stable body weight (<4 kg weight loss or weight gain) for 6 months prior to the start of the study
Exclusion Criteria:
- Those with chronic disease (diabetes, hypertension, cardiovascular disease, etc.)
- Drug users
- Use of supplements that may affect blood lipid profile and blood sugar (omega-3 etc.)
- Pregnant women
- People in the lactation period
- Menopause
- Shift workers
- Those who follow a Time Restricted (16:8) nutrition program before the study
- Those who have followed any particular diet before the study
- Those who frequently apply different weight loss diet programs
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Time restricted feeding
The participants in the intervention group will receive a time restricted feeding intervention (first meal at 10:00, last meal at 18:00) for 6 weeks.
Meals of the participants are planned as 8 hours of eating and 16 hours of fasting.
|
In the time-restricted nutrition intervention, the first meal is scheduled at 10:00 and the last meal at 18:00 (ad libitum).
Eating for 8 hours and fasting for 16 hours are targeted.
|
|
No Intervention: Control
Participants in the control group will not receive any dietary intervention.
All participants were asked to continue in the same way they were fed before starting the study throughout the study.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Body Weight
Time Frame: 6 week
|
Body Weight
|
6 week
|
|
Body Composition
Time Frame: 6 week
|
total body fluid
|
6 week
|
|
Body Composition
Time Frame: 6 week
|
total fat mass
|
6 week
|
|
Body Composition
Time Frame: 6 week
|
muscle mass
|
6 week
|
|
Body Composition
Time Frame: 6 week
|
fat free mass
|
6 week
|
|
Plasma lipids
Time Frame: 6 week
|
Total cholesterol
|
6 week
|
|
Plasma lipids
Time Frame: 6 week
|
Hdl cholesterol
|
6 week
|
|
Plasma lipids
Time Frame: 6 week
|
Ldl cholesterol
|
6 week
|
|
Plasma lipids
Time Frame: 6 week
|
Triglyceride
|
6 week
|
|
Blood Pressure
Time Frame: 6 week
|
Systolic blood pressure
|
6 week
|
|
Blood Pressure
Time Frame: 6 week
|
Diastolic blood pressure
|
6 week
|
|
Pulse
Time Frame: 6 week
|
6 week
|
|
|
Biochemistry
Time Frame: 6 week
|
blood glucose
|
6 week
|
|
Biochemistry
Time Frame: 6 week
|
fasting insulin
|
6 week
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: AYŞEN YILDIRIM KIZILDAĞ, PhD, Eastern Mediterranean University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- AYildirim
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fasting
-
University of BariCompleted
-
University of GuelphCompletedRamadan FastingCanada
-
University of ChileAgencia Nacional de Investigación y DesarrolloCompletedIntermittent Fasting in Shift-workChile
-
Charite University, Berlin, GermanySoftware AG Stiftung; Eden Stiftung; Reformhaus StiftungEnrolling by invitation
-
University of California, San DiegoRecruitingDepression - Major Depressive DisorderUnited States
-
USDA, Western Human Nutrition Research CenterUniversity of California, DavisCompletedCardiovascular Risk Factor | Athletic Performance | Fasting | Resting Energy Expenditure | Intermittent FastingUnited States
-
Sanliurfa Education and Research HospitalEnrolling by invitation
-
King Faisal UniversitySaudi Food and Drug AuthorityRecruitingDietary Intervention | Glycemic Response; Satiety | Postprandial Glucose | Fasting, Time RestrictedSaudi Arabia
-
Desitin Arzneimittel GmbHBioPharma Services, IncCompleted
-
Beth Israel Deaconess Medical CenterCompleted
Clinical Trials on Time restricted feeding
-
Chung-Ang UniversityNational Research Foundation of KoreaCompletedNutritional and Metabolic Diseases | Body Weight MaintenanceKorea, Republic of
-
Hospital Universitari Vall d'Hebron Research InstituteRecruitingObesity and Obesity-related Medical ConditionsSpain
-
Assistance Publique - Hôpitaux de ParisNational Research Agency, FranceRecruitingObesity and Obesity-related Medical ConditionsFrance
-
Qingdao UniversityUnknownFeeding BehaviorChina
-
Harokopio UniversityCompletedCircadian Rhythm | Appetite | Metabolic Health | Body Weight Control | Glycemic and Insulinemic ResponseGreece
-
University of Alabama at BirminghamNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedMultiple Sclerosis | Diet, HealthyUnited States
-
Kyle HackneyUniversity of NebraskaCompletedWeight Loss | Overweight and ObesityUnited States
-
University of GuadalajaraRecruiting
-
Instituto de Nutrición y Tecnología de los AlimentosUniversidad Católica del Maule; Agencia Nacional de Investigación y DesarrolloCompletedIntermittent Fasting | Metabolically Healthy ObesityChile
-
Peking University Third HospitalRecruitingType 2 Diabetes MellitusChina